Andfjord Salmon (ANDF) Company presentation summary
Event summary combining transcript, slides, and related documents.
Company presentation summary
23 Apr, 2026Production technology and operational performance
Flow-through production method combines benefits of sea-based and land-based salmon farming, using ocean water onshore for optimal conditions and low energy costs.
No salmon lice, no risk of escapes, and organic waste is recirculated as a commercial resource.
Excellent biological performance with industry-leading survival rates (99.4% in 2025-26 batches) and strong growth exceeding expectations.
Full-year production enabled by stable, controlled environments and low energy consumption.
First production cycle in 2023 achieved a 97.5% survival rate and 40% higher average weight at harvest than expected.
Expansion, infrastructure, and capacity
Construction at Kvalnes is on track, with two pools operational and more pools scheduled for completion in 2026.
Operational capacity expected to reach 11,000 tons by H1 2026, scaling to 17,000 tons with Phase 2a, and up to 28,800 tons pending license expansion.
Significant shared infrastructure investments support a long-term production potential of 48,100 tons at Kvalnes and up to 90,000 tons across all sites.
Expansion plan leverages existing infrastructure to keep capex down while increasing production volumes.
Each pool is designed as an individual biozone, reducing contamination risk and supporting biosecurity.
Strategic partnerships and commercial agreements
NOK 100m strategic investment from Eidsfjord Sjøfarm/Holmøy Havbruk, securing post-smolt deliveries and processing agreements through H1 2027.
Partnership enables integrated value chain, shorter production cycles, and higher MAB utilization, accelerating time-to-revenue.
~1 million post-smolt contracted for 2026, with options to extend contract length.
Processing capacity secured at Holmøy's automated facility, supporting harvest execution certainty.
Latest events from Andfjord Salmon
- Survival rates above 99% and strong growth drive expansion amid ongoing legal dispute.ANDF
Q1 2026 - Survival rates above 99.5% and rapid growth drive expansion toward 11,000t capacity in 2026.ANDF
Q4 2025 - First salmon sales, high survival rates, and major capital raise drive expansion.ANDF
Q3 2025 - Raised NOK 1.55 billion, completed infrastructure, and prepares for large-scale smolt release.ANDF
Q2 2025 - Kvalnes expansion advances ahead of schedule, with strong liquidity and regulatory stability.ANDF
Q3 2024 - Kvalnes expansion accelerates, equity raised, and "post-smolt" strategy to lift EBIT.ANDF
Q2 2024 - Kvalnes nears completion with 20% capacity boost, full funding, and regulatory readiness.ANDF
Investor Update - Q1 2025 loss of NOK 18M, 20% capacity boost, NOK 400M equity raised, smolt release set for Q3.ANDF
Q1 2025 - Strong asset and revenue growth in 2024 with industry-leading operational progress.ANDF
Q4 2024